“…Radiation-attenuated sporozoites have been used to produce sterilizing immunity, but this method remains impractical for widespread use due to logistical constraints [2]. Furthermore, the most advanced malaria vaccine candidate, RTS,S/AS01, has failed to produce long-lived efficacy [6, 7], likely due to lack of CD8 + T cell responses induced and its design based on a single pre-erythrocytic stage antigen target, CSP [8], as a single sporozoite that evades immune responses induced against CSP can produce tens of thousands of blood stage merozoites [2, 9, 10]. Moreover, preclinical murine studies on a vaccine candidate based on two pre-erythrocytic-stage antigens, CSP and the thrombospondin-related adhesive protein (TRAP), have not shown increased efficacy compared to single antigen vaccines [11].…”